CCXI - ChemoCentryx, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue42,87582,49711,935-
Cost of Revenue62,73649,49537,94533,183
Gross Profit-19,86133,002-26,010-33,183
Operating Expenses
Research Development----
Selling General and Administrative20,40916,50914,71014,506
Non Recurring----
Others----
Total Operating Expenses83,14566,00452,65547,689
Operating Income or Loss-40,27016,493-40,720-47,689
Income from Continuing Operations
Total Other Income/Expenses Net2,3041,366757384
Earnings Before Interest and Taxes-40,27016,493-40,720-47,689
Interest Expense-1,224-4-4-4
Income Before Tax-37,96617,859-39,963-47,305
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-37,96617,859-39,963-47,305
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-37,96617,859-39,963-47,305
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-37,96617,859-39,963-47,305